GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.66 Cr | ₹1.30 Cr | ₹1.02 Cr | ₹0.98 Cr | ₹0.86 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹1.66 Cr |
Mar2023 | ₹1.30 Cr |
Mar2022 | ₹1.02 Cr |
Mar2021 | ₹0.98 Cr |
Mar2020 | ₹0.86 Cr |
How is Deferred Tax Assets / Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.66 Cr | 28.00 | |
Mar2023 | ₹1.30 Cr | 26.95 | |
Mar2022 | ₹1.02 Cr | 4.60 | |
Mar2021 | ₹0.98 Cr | 13.31 | |
Mar2020 | ₹0.86 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹3,552.9 Cr | -0.6% | 9% | 156.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -0.6% |
9% |
156.8% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses